By Kelly Cloonan

Shares of CapsoVision climbed in the medical-technology company's second day of trading on the Nasdaq.

The stock edged up 26%, to $4.41, midday Thursday, after ending Wednesday down following its trading debut.

CapsoVision said Thursday it closed its initial public offering of 5.5 million shares of common stock at $5 apiece. Prior to the IPO, the company anticipated a price range of $5 to $5.50 a share, according to filings with the Securities and Exchange Commission.

The gross proceeds from the offering before underwriting discounts, commissions and other expenses were $27.5 million, the Saratoga, Calif., company said.

Underwriters have been granted a 30-day option to purchase up to an additional 825,000 shares at the public offering price, the company said.

The Benchmark Company and Roth Capital Partners acted as joint book-running managers for the offering, the company said.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

July 03, 2025 12:32 ET (16:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.